To determine the therapeutic potential of Listerin, adenovirus‐mediated overexpression of Listerin (Adv‐GFP‐Listerin) was used in the Aβ induced‐AD model (Figure 7A). The gene discussed is LTN1; the disease is Alzheimer disease.